55 related articles for article (PubMed ID: 38644367)
21. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer.
Hamstra DA; Stenmark MH; Ritter T; Litzenberg D; Jackson W; Johnson S; Albrecht-Unger L; Donaghy A; Phelps L; Blas K; Halverson S; Marsh R; Olson K; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1246-53. PubMed ID: 23265567
[TBL] [Abstract][Full Text] [Related]
22. Salvage intensity-modulated radiation therapy for locally recurrent prostate cancer after cryotherapy.
Choi M; Kim CR; Hung AY
Clin Genitourin Cancer; 2013 Jun; 11(2):85-8. PubMed ID: 23041454
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer.
Donnelly BJ; Saliken JC; Brasher PM; Ernst SD; Rewcastle JC; Lau H; Robinson J; Trpkov K
Cancer; 2010 Jan; 116(2):323-30. PubMed ID: 19937954
[TBL] [Abstract][Full Text] [Related]
24. Cryosurgery for prostate cancer: an update on clinical results of modern cryotechnology.
Langenhuijsen JF; Broers EM; Vergunst H
Eur Urol; 2009 Jan; 55(1):76-86. PubMed ID: 18789572
[TBL] [Abstract][Full Text] [Related]
25. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
26. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
Roach M; Hanks G; Thames H; Schellhammer P; Shipley WU; Sokol GH; Sandler H
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):965-74. PubMed ID: 16798415
[TBL] [Abstract][Full Text] [Related]
27. The molecular basis of cryosurgery.
Baust JG; Gage AA
BJU Int; 2005 Jun; 95(9):1187-91. PubMed ID: 15892798
[No Abstract] [Full Text] [Related]
28. Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer.
McDonough MJ; Feldmeier JJ; Parsai I; Dobelbower RR; Selman SH
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):624-7. PubMed ID: 11597801
[TBL] [Abstract][Full Text] [Related]
29. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate.
Long JP; Bahn D; Lee F; Shinohara K; Chinn DO; Macaluso JN
Urology; 2001 Mar; 57(3):518-23. PubMed ID: 11248631
[TBL] [Abstract][Full Text] [Related]
30. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation.
Burton S; Brown DM; Colonias A; Cohen J; Miller R; Rooker G; Benoit R; Merlotti L; Quinn A; Kalnicki S
Urology; 2000 Nov; 56(5):833-8. PubMed ID: 11068312
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of tissue injury in cryosurgery.
Gage AA; Baust J
Cryobiology; 1998 Nov; 37(3):171-86. PubMed ID: 9787063
[TBL] [Abstract][Full Text] [Related]
32. Salvage prostate intensity modulated radiation therapy after cryotherapy failure.
Perennec T; Rogé M; Hetet JF; Colls P; Guimas V; Rio E; Vaugier L; Supiot S
Sci Rep; 2024 Apr; 14(1):9148. PubMed ID: 38644367
[TBL] [Abstract][Full Text] [Related]
33. Salvage radiotherapy after initial cryotherapy for localized prostate cancer: A systematic review of the literature.
Rogé M; Perennec T; Guimas V; Hetet JF; Rio E; Vaugier L; Supiot S
Crit Rev Oncol Hematol; 2023 Dec; 192():104149. PubMed ID: 37813320
[TBL] [Abstract][Full Text] [Related]
34. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
35. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
Valle LF; Lehrer EJ; Markovic D; Elashoff D; Levin-Epstein R; Karnes RJ; Reiter RE; Rettig M; Calais J; Nickols NG; Dess RT; Spratt DE; Steinberg ML; Nguyen PL; Davis BJ; Zaorsky NG; Kishan AU
Eur Urol; 2021 Sep; 80(3):280-292. PubMed ID: 33309278
[TBL] [Abstract][Full Text] [Related]
36. [Salvage brachytherapy for prostate cancer biochemical recurrence after radiotherapy].
Rubio AP; López IJ
Arch Esp Urol; 2012; 65(1):145-57. PubMed ID: 22318185
[TBL] [Abstract][Full Text] [Related]
37. [Salvage cryotherapy for recurrent prostate cancer after radiotherapy failure: principles, indications, patient selection, oncological results and morbidity].
Hétet JF; Colls P; Pocholle P; Chauveau P; Barré C; Hallouin P
Cancer Radiother; 2014 Nov; 18(7):701-8. PubMed ID: 24910288
[TBL] [Abstract][Full Text] [Related]
38. Cancer control and complications of salvage local therapy after failure of radiotherapy for prostate cancer: a systematic review.
Parekh A; Graham PL; Nguyen PL
Semin Radiat Oncol; 2013 Jul; 23(3):222-34. PubMed ID: 23763889
[TBL] [Abstract][Full Text] [Related]
39. Salvage therapy for locally recurrent prostate cancer after radiation.
Marcus DM; Canter DJ; Jani AB; Dobbs RW; Schuster DM; Carthon BC; Rossi PJ
Can J Urol; 2012 Dec; 19(6):6534-41. PubMed ID: 23228288
[TBL] [Abstract][Full Text] [Related]
40. Salvage local treatment for localized radio-recurrent prostate cancer: a narrative review and future perspectives.
Büchser D; Medina R; Mayrata E; González A; Marban M; Achard V; Alongi F; Gomez-Iturriaga A; Couñago F
Future Oncol; 2021 Nov; 17(31):4207-4219. PubMed ID: 34448402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
